Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 07:45:01 - browse：3

Silhouette of a person with short hair taking a sip of red wine in a winery — coverage from STAT — MARCO BERTORELLO/AFP via Getty Images

In 1995, when Marion Nestle was on the committee drafting the Dietary Guidelines for Americans, things were run differently. She and other experts handled it all: deciding on nutrition-related research questions, collecting the evidence, issuing a scientific report, and then writing guidance for how Americans should eat.

When it came time for that last part — the writing — Nestle and two co-authors got together at a bar, ordered glasses of wine, and got to work. “I’m not kidding,” she said. At the time, the research suggested small amounts of alcohol reduced the risk of heart disease. The guidelines reflected that. “Alcoholic beverages have been used to enhance the enjoyment of meals by many societies throughout human history,” read a part of the 1995 document (a note Nestle says was added last-minute by a federal official who believed in wine’s benefits).

The issue of alcohol — and how much of it Americans should consume — is up for debate again as the dietary guidelines undergo updates and revisions, due in 2025. Already, there’s simmering debate over a growing body of research, plus clashing of interests and the same specter of controversy that’s followed the report since Nestle’s time.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： 3 questions for the future of Biden's cancer moonshot

WSS

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

FDA rejects Alnylam's heart disease treatment over insufficient data

Secretariat’s lessons for human medicine

Chemotherapy drug shortage eases slightly but still widespread

Opioid cravings were reduced by anti

Was Amgen transparent enough on FDA's concern on cancer drug?

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

VC firm General Catalyst wants to buy a health system

How one medical school became remarkably diverse

Flagship Pioneering startup Sonata Therapeutics lays off 21

The cancer drug shortage isn’t new — and neither are the solutions

3 questions for the future of Biden's cancer moonshot

The cancer drug shortage isn’t new — and neither are the solutions

A virus, fished out of a lake, may have saved a man’s life

Cancer drug shortages should be causing more outrage

MD Anderson's Padmanee Sharma responds to research credit suit

hotspot

3 questions for the future of Biden's cancer moonshot

When women are denied an abortion, their children fare worse than peers

Researchers tackle phage therapy hurdles for wider adoption

Surprise medical billing ban raises prices elsewhere

Liquid biopsy for lung cancer is launched by Delfi

FDA warns medical device makers about rise in fabricated data

knowledge

entertainment

focus

focus